Caspofungin represents the echinocandins, a new class of antifungal agent. These drugs inhibit beta-glucan synthase, thereby blocking the synthesis of beta-(1,3)-D-glucan, a component found in cell walls of filamentous fungi. Caspofungin has activity against _Aspergillus_ and _Candida_ species and is effective in treating pneumonia caused by _Pneumocystis carinii_ . Because it contains very little beta-glucan synthase, _Cryptococcus neoformans_ infections are not effectively treated with caspofungin.
Cefaclor may potentially be useful when an oral cephalosporin is desired to treat infections that are susceptible to it but resistant to first generation cephalosporins such as cephalexin or cefadroxil. Little information is available with regard to its clinical use in small animals, however.
劑量數字暫停提供：VetPro 的劑量改依 DRUGAPI 藥物資料庫對外的內容，DRUGAPI 目前不提供可直接計算的劑量。下方列出 DRUGAPI 的審查結論與劑量審查引用的來源；計算機可手動輸入劑量換算。
依出現頻率分組；嚴重副作用獨立列出，臨床上需立即辨識。
2 hours